Previous weight loss attempts and why they succeeded or failed
New Study Highlights Superiority of Bariatric Surgery Over GLP-1 Medications for Sustained Weight Loss A new real-world study presented at the ASMBS 2025 Annual Meeting compares outcomes between GLP-1 medications (such as semaglutide and tirzepatide) and bariatric surgery
An outline of the MD simulations performed on the GLP-1R bound to Ex4-L-Ala ( a ), Ex4 ( b ) and Ex4-D-Ala ( c )
The peptides and gut health relationship is complex, and some people find that adding supportive gut health peptides alongside retatrutide eases the transition
Managing side effects is a common reason people look for supplements alongside their GLP-1 medications
Investors are focusing on companies developing novel GLP-1, dual agonist, and multi-receptor therapies, while pharmaceutical manufacturers continue to invest heavily in production capacity and strategic acquisitions to strengthen their obesity and diabetes portfolios
